296 related articles for article (PubMed ID: 33834345)
1. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
2. Retinal and Choroidal Changes of Vitreoretinal Lymphoma from Active to Remission Phase after Intravitreal Rituximab.
Cicinelli MV; Marchese A; Miserocchi E; Giuffré C; Berchicci L; Querques G; Bandello F; Modorati GM
Ocul Immunol Inflamm; 2020 May; 28(4):637-646. PubMed ID: 31393199
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal rituximab monotherapy for management of eyes with vitreoretinal lymphoma: initial experience from India.
Rishi P; Manchegowda PT; Gondhale HP; Rishi E; Das K; Krishnakumar S; Raja T; Biswas J
Int Ophthalmol; 2021 Jul; 41(7):2495-2504. PubMed ID: 33730314
[TBL] [Abstract][Full Text] [Related]
4. ULTRA-WIDEFIELD MULTIMODAL IMAGING OF PRIMARY VITREORETINAL LYMPHOMA.
Lavine JA; Singh AD; Sharma S; Baynes K; Lowder CY; Srivastava SK
Retina; 2019 Oct; 39(10):1861-1871. PubMed ID: 30044267
[TBL] [Abstract][Full Text] [Related]
5. Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate.
Jiang T; Gu J; Liu S; Chang Q
BMC Ophthalmol; 2022 Sep; 22(1):375. PubMed ID: 36127675
[TBL] [Abstract][Full Text] [Related]
6. Fundus autofluorescence patterns in primary intraocular lymphoma.
Casady M; Faia L; Nazemzadeh M; Nussenblatt R; Chan CC; Sen HN
Retina; 2014 Feb; 34(2):366-72. PubMed ID: 23958842
[TBL] [Abstract][Full Text] [Related]
7. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
[TBL] [Abstract][Full Text] [Related]
8. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
9. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
Tang F; Qin X; Lu J; Song P; Li M; Ma X
Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Imaging of Vitreoretinal Lymphoma.
Mapelli C; Invernizzi A; Barteselli G; Pellegrini M; Tabacchi E; Staurenghi G; Viola F
Ophthalmologica; 2016; 236(3):166-174. PubMed ID: 27627063
[TBL] [Abstract][Full Text] [Related]
11. Swept-source optical coherence tomography angiography findings in a case of primary vitreoretinal lymphoma over a three-year follow-up.
Maggio E; Bauci F; Polito A; Arena F; Pertile G
BMC Ophthalmol; 2024 Apr; 24(1):194. PubMed ID: 38664667
[TBL] [Abstract][Full Text] [Related]
12. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
13. Paraneoplastic cloudy vitelliform submaculopathy in primary vitreoretinal lymphoma.
Pang CE; Shields CL; Jumper JM; Yannuzzi LA
Am J Ophthalmol; 2014 Dec; 158(6):1253-1261.e2. PubMed ID: 25174893
[TBL] [Abstract][Full Text] [Related]
14. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
[TBL] [Abstract][Full Text] [Related]
15. Familial Exudative Vitreoretinopathy: Spectral-Domain Optical Coherence Tomography of the Vitreoretinal Interface, Retina, and Choroid.
Yonekawa Y; Thomas BJ; Drenser KA; Trese MT; Capone A
Ophthalmology; 2015 Nov; 122(11):2270-7. PubMed ID: 26299697
[TBL] [Abstract][Full Text] [Related]
16. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Delhiwala K
Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
[TBL] [Abstract][Full Text] [Related]
17. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration.
Shah VP; Shah SA; Mrejen S; Freund KB
Retina; 2014 Jul; 34(7):1281-8. PubMed ID: 24695062
[TBL] [Abstract][Full Text] [Related]
18. Changes in choroidal vascular structure from vitreoretinal lymphoma and the intraocular cytokine level associated with clinical resolution after intravitreal methotrexate treatment.
Kim RY; Park JH; Kim M; Park YG; Cho SG; Park YH
PLoS One; 2021; 16(11):e0260469. PubMed ID: 34813633
[TBL] [Abstract][Full Text] [Related]
19. ULTRA-WIDE FIELD FUNDUS AUTOFLUORESCENCE IMAGING OF EYES WITH STICKLER SYNDROME.
Fujimoto K; Nagata T; Matsushita I; Oku K; Imagawa M; Kuniyoshi K; Hayashi T; Kimoto K; Ohji M; Kusaka S; Kondo H
Retina; 2021 Mar; 41(3):638-645. PubMed ID: 32639332
[TBL] [Abstract][Full Text] [Related]
20. Sequential multimodal imaging findings in a case of primary vitreoretinal lymphoma.
Dolz-Marco R; Gallego-Pinazo R; Jung JJ; Freund KB; Díaz-Llopis M
Retin Cases Brief Rep; 2014; 8(4):314-7. PubMed ID: 25372536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
